Loading…
Toenail iron, genetic determinants of iron status, and the risk of glioma
Purpose: Iron is essential for oxygen transport and oxidative metabolism; however, elevated iron stores can trigger overproduction of reactive oxygen species and induce DNA damage. Little is known about the association between body iron stores and glioma risk. This study examined the associations of...
Saved in:
Published in: | Cancer causes & control 2013-12, Vol.24 (12), p.2051-2058 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c492t-3b67fb3b9ea84c7ecef3cc76a409054c2072528569a1e39a35df947914a844373 |
---|---|
cites | cdi_FETCH-LOGICAL-c492t-3b67fb3b9ea84c7ecef3cc76a409054c2072528569a1e39a35df947914a844373 |
container_end_page | 2058 |
container_issue | 12 |
container_start_page | 2051 |
container_title | Cancer causes & control |
container_volume | 24 |
creator | Anic, Gabriella M. Madden, Melissa H. Thompson, Reid C. Nabors, L. Burton Olson, Jeffrey J. LaRocca, Renato V. Browning, James E. Brockman, John D. Forsyth, Peter A. Egan, Kathleen M. |
description | Purpose: Iron is essential for oxygen transport and oxidative metabolism; however, elevated iron stores can trigger overproduction of reactive oxygen species and induce DNA damage. Little is known about the association between body iron stores and glioma risk. This study examined the associations of iron levels measured in toenails and genetic variants linked to body iron stores with risk of glioma in a clinic-based case–control study. Methods: Samples were collected a median of 24 days following glioma diagnosis in the cases (10th–90th percentile, range: 10–44 days). Nail iron levels were measured in 300 cases and 300 controls using neutron activation analysis. A total of 24 genetic variants associated with iron status were genotyped in 622 cases and 628 controls. Logistic regression was used to estimate odds ratios (OR) and 95 % confidence intervals (CI) for glioma risk according to toenail iron and the examined genotypes. Results: No association was observed between toenail iron and glioma risk when restricting to cases with nails collected within ∼3 weeks of diagnosis (OR = 0.93; 95 % CI 0.46, 1.87 comparing those with high (≥14 μ/g) vs. low ( |
doi_str_mv | 10.1007/s10552-013-0281-2 |
format | article |
fullrecord | <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3823695</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>24717889</jstor_id><sourcerecordid>24717889</sourcerecordid><originalsourceid>FETCH-LOGICAL-c492t-3b67fb3b9ea84c7ecef3cc76a409054c2072528569a1e39a35df947914a844373</originalsourceid><addsrcrecordid>eNp9kU9v1DAQxS1ERZfCB-AAisSFQwPjf3F8qYSqApUqcSlny-udbL0kdrEdJL59vU0pbQ-c5vB-782MHiFvKHykAOpTpiAla4HyFlhPW_aMrKhUvFWMyedkBVqqVjLBD8nLnHcAIDsGL8gh41p3VLMVOb-MGKwfG59iOG62GLB412ywYJp8sKHkJg63apOLLXM-bmzYNOUKm-Tzz724HX2c7CtyMNgx4-u7eUR-fDm7PP3WXnz_en76-aJ1QrPS8nWnhjVfa7S9cAodDtw51VkBGqRwDBSTrJedthS5tlxuBi2UpqLygit-RE6W3Ot5PeHGYSjJjuY6-cmmPyZabx4rwV-ZbfxteM94p2UN-HAXkOKvGXMxk88Ox9EGjHM2VNRDe-BcV_T9E3QX5xTqe3uq7wEYQKXoQrkUc0443B9DweyLMktRphZl9kUZVj3vHn5x7_jbTAXYAuQqhS2mB6v_k_p2Me1yielfqFBU9b3mN0vKpqo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1448800200</pqid></control><display><type>article</type><title>Toenail iron, genetic determinants of iron status, and the risk of glioma</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>Springer Link</source><creator>Anic, Gabriella M. ; Madden, Melissa H. ; Thompson, Reid C. ; Nabors, L. Burton ; Olson, Jeffrey J. ; LaRocca, Renato V. ; Browning, James E. ; Brockman, John D. ; Forsyth, Peter A. ; Egan, Kathleen M.</creator><creatorcontrib>Anic, Gabriella M. ; Madden, Melissa H. ; Thompson, Reid C. ; Nabors, L. Burton ; Olson, Jeffrey J. ; LaRocca, Renato V. ; Browning, James E. ; Brockman, John D. ; Forsyth, Peter A. ; Egan, Kathleen M.</creatorcontrib><description>Purpose: Iron is essential for oxygen transport and oxidative metabolism; however, elevated iron stores can trigger overproduction of reactive oxygen species and induce DNA damage. Little is known about the association between body iron stores and glioma risk. This study examined the associations of iron levels measured in toenails and genetic variants linked to body iron stores with risk of glioma in a clinic-based case–control study. Methods: Samples were collected a median of 24 days following glioma diagnosis in the cases (10th–90th percentile, range: 10–44 days). Nail iron levels were measured in 300 cases and 300 controls using neutron activation analysis. A total of 24 genetic variants associated with iron status were genotyped in 622 cases and 628 controls. Logistic regression was used to estimate odds ratios (OR) and 95 % confidence intervals (CI) for glioma risk according to toenail iron and the examined genotypes. Results: No association was observed between toenail iron and glioma risk when restricting to cases with nails collected within ∼3 weeks of diagnosis (OR = 0.93; 95 % CI 0.46, 1.87 comparing those with high (≥14 μ/g) vs. low (<6 μ/g) iron levels). In contrast, an inverse association with increasing iron was observed after restricting to cases with a delay of 3 weeks or greater (OR = 0.42; 95 % CI 0.19, 0.95), reflecting potentially insidious effects of advancing disease on iron levels among the cases. No associations were observed for any of the examined genetic variants. Conclusion: The results do not support a role for body iron stores as a determinant of glioma risk.</description><identifier>ISSN: 0957-5243</identifier><identifier>EISSN: 1573-7225</identifier><identifier>DOI: 10.1007/s10552-013-0281-2</identifier><identifier>PMID: 23996192</identifier><identifier>CODEN: CCCNEN</identifier><language>eng</language><publisher>Dordrecht: Springer</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Alleles ; Biomedical and Life Sciences ; Biomedicine ; Brain cancer ; Brain Neoplasms - blood ; Brain Neoplasms - epidemiology ; Brain Neoplasms - genetics ; Brain research ; Cancer ; Cancer Research ; Case-Control Studies ; Dietary iron ; DNA damage ; DNA, Neoplasm - genetics ; Epidemiology ; Female ; Ferritins - blood ; Follow-Up Studies ; Genetic testing ; Genotype ; Genotypes ; Glioma ; Glioma - blood ; Glioma - epidemiology ; Glioma - genetics ; Hematology ; Humans ; Iron ; Iron - metabolism ; Iron, Dietary ; Male ; Medical genetics ; Metabolism ; Middle Aged ; Nails - chemistry ; Neoplasm Grading ; Neoplasm Proteins - genetics ; Neurosurgery ; Oncology ; Original Paper ; P values ; Polymerase Chain Reaction ; Prognosis ; Public Health ; Risk Factors ; Survival Rate ; Toenails ; Tumors ; Young Adult</subject><ispartof>Cancer causes & control, 2013-12, Vol.24 (12), p.2051-2058</ispartof><rights>Springer Science+Business Media 2013</rights><rights>Springer Science+Business Media Dordrecht 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c492t-3b67fb3b9ea84c7ecef3cc76a409054c2072528569a1e39a35df947914a844373</citedby><cites>FETCH-LOGICAL-c492t-3b67fb3b9ea84c7ecef3cc76a409054c2072528569a1e39a35df947914a844373</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/24717889$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/24717889$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,776,780,881,27903,27904,58216,58449</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23996192$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anic, Gabriella M.</creatorcontrib><creatorcontrib>Madden, Melissa H.</creatorcontrib><creatorcontrib>Thompson, Reid C.</creatorcontrib><creatorcontrib>Nabors, L. Burton</creatorcontrib><creatorcontrib>Olson, Jeffrey J.</creatorcontrib><creatorcontrib>LaRocca, Renato V.</creatorcontrib><creatorcontrib>Browning, James E.</creatorcontrib><creatorcontrib>Brockman, John D.</creatorcontrib><creatorcontrib>Forsyth, Peter A.</creatorcontrib><creatorcontrib>Egan, Kathleen M.</creatorcontrib><title>Toenail iron, genetic determinants of iron status, and the risk of glioma</title><title>Cancer causes & control</title><addtitle>Cancer Causes Control</addtitle><addtitle>Cancer Causes Control</addtitle><description>Purpose: Iron is essential for oxygen transport and oxidative metabolism; however, elevated iron stores can trigger overproduction of reactive oxygen species and induce DNA damage. Little is known about the association between body iron stores and glioma risk. This study examined the associations of iron levels measured in toenails and genetic variants linked to body iron stores with risk of glioma in a clinic-based case–control study. Methods: Samples were collected a median of 24 days following glioma diagnosis in the cases (10th–90th percentile, range: 10–44 days). Nail iron levels were measured in 300 cases and 300 controls using neutron activation analysis. A total of 24 genetic variants associated with iron status were genotyped in 622 cases and 628 controls. Logistic regression was used to estimate odds ratios (OR) and 95 % confidence intervals (CI) for glioma risk according to toenail iron and the examined genotypes. Results: No association was observed between toenail iron and glioma risk when restricting to cases with nails collected within ∼3 weeks of diagnosis (OR = 0.93; 95 % CI 0.46, 1.87 comparing those with high (≥14 μ/g) vs. low (<6 μ/g) iron levels). In contrast, an inverse association with increasing iron was observed after restricting to cases with a delay of 3 weeks or greater (OR = 0.42; 95 % CI 0.19, 0.95), reflecting potentially insidious effects of advancing disease on iron levels among the cases. No associations were observed for any of the examined genetic variants. Conclusion: The results do not support a role for body iron stores as a determinant of glioma risk.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alleles</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brain cancer</subject><subject>Brain Neoplasms - blood</subject><subject>Brain Neoplasms - epidemiology</subject><subject>Brain Neoplasms - genetics</subject><subject>Brain research</subject><subject>Cancer</subject><subject>Cancer Research</subject><subject>Case-Control Studies</subject><subject>Dietary iron</subject><subject>DNA damage</subject><subject>DNA, Neoplasm - genetics</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Ferritins - blood</subject><subject>Follow-Up Studies</subject><subject>Genetic testing</subject><subject>Genotype</subject><subject>Genotypes</subject><subject>Glioma</subject><subject>Glioma - blood</subject><subject>Glioma - epidemiology</subject><subject>Glioma - genetics</subject><subject>Hematology</subject><subject>Humans</subject><subject>Iron</subject><subject>Iron - metabolism</subject><subject>Iron, Dietary</subject><subject>Male</subject><subject>Medical genetics</subject><subject>Metabolism</subject><subject>Middle Aged</subject><subject>Nails - chemistry</subject><subject>Neoplasm Grading</subject><subject>Neoplasm Proteins - genetics</subject><subject>Neurosurgery</subject><subject>Oncology</subject><subject>Original Paper</subject><subject>P values</subject><subject>Polymerase Chain Reaction</subject><subject>Prognosis</subject><subject>Public Health</subject><subject>Risk Factors</subject><subject>Survival Rate</subject><subject>Toenails</subject><subject>Tumors</subject><subject>Young Adult</subject><issn>0957-5243</issn><issn>1573-7225</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp9kU9v1DAQxS1ERZfCB-AAisSFQwPjf3F8qYSqApUqcSlny-udbL0kdrEdJL59vU0pbQ-c5vB-782MHiFvKHykAOpTpiAla4HyFlhPW_aMrKhUvFWMyedkBVqqVjLBD8nLnHcAIDsGL8gh41p3VLMVOb-MGKwfG59iOG62GLB412ywYJp8sKHkJg63apOLLXM-bmzYNOUKm-Tzz724HX2c7CtyMNgx4-u7eUR-fDm7PP3WXnz_en76-aJ1QrPS8nWnhjVfa7S9cAodDtw51VkBGqRwDBSTrJedthS5tlxuBi2UpqLygit-RE6W3Ot5PeHGYSjJjuY6-cmmPyZabx4rwV-ZbfxteM94p2UN-HAXkOKvGXMxk88Ox9EGjHM2VNRDe-BcV_T9E3QX5xTqe3uq7wEYQKXoQrkUc0443B9DweyLMktRphZl9kUZVj3vHn5x7_jbTAXYAuQqhS2mB6v_k_p2Me1yielfqFBU9b3mN0vKpqo</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>Anic, Gabriella M.</creator><creator>Madden, Melissa H.</creator><creator>Thompson, Reid C.</creator><creator>Nabors, L. Burton</creator><creator>Olson, Jeffrey J.</creator><creator>LaRocca, Renato V.</creator><creator>Browning, James E.</creator><creator>Brockman, John D.</creator><creator>Forsyth, Peter A.</creator><creator>Egan, Kathleen M.</creator><general>Springer</general><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20131201</creationdate><title>Toenail iron, genetic determinants of iron status, and the risk of glioma</title><author>Anic, Gabriella M. ; Madden, Melissa H. ; Thompson, Reid C. ; Nabors, L. Burton ; Olson, Jeffrey J. ; LaRocca, Renato V. ; Browning, James E. ; Brockman, John D. ; Forsyth, Peter A. ; Egan, Kathleen M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c492t-3b67fb3b9ea84c7ecef3cc76a409054c2072528569a1e39a35df947914a844373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alleles</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brain cancer</topic><topic>Brain Neoplasms - blood</topic><topic>Brain Neoplasms - epidemiology</topic><topic>Brain Neoplasms - genetics</topic><topic>Brain research</topic><topic>Cancer</topic><topic>Cancer Research</topic><topic>Case-Control Studies</topic><topic>Dietary iron</topic><topic>DNA damage</topic><topic>DNA, Neoplasm - genetics</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Ferritins - blood</topic><topic>Follow-Up Studies</topic><topic>Genetic testing</topic><topic>Genotype</topic><topic>Genotypes</topic><topic>Glioma</topic><topic>Glioma - blood</topic><topic>Glioma - epidemiology</topic><topic>Glioma - genetics</topic><topic>Hematology</topic><topic>Humans</topic><topic>Iron</topic><topic>Iron - metabolism</topic><topic>Iron, Dietary</topic><topic>Male</topic><topic>Medical genetics</topic><topic>Metabolism</topic><topic>Middle Aged</topic><topic>Nails - chemistry</topic><topic>Neoplasm Grading</topic><topic>Neoplasm Proteins - genetics</topic><topic>Neurosurgery</topic><topic>Oncology</topic><topic>Original Paper</topic><topic>P values</topic><topic>Polymerase Chain Reaction</topic><topic>Prognosis</topic><topic>Public Health</topic><topic>Risk Factors</topic><topic>Survival Rate</topic><topic>Toenails</topic><topic>Tumors</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anic, Gabriella M.</creatorcontrib><creatorcontrib>Madden, Melissa H.</creatorcontrib><creatorcontrib>Thompson, Reid C.</creatorcontrib><creatorcontrib>Nabors, L. Burton</creatorcontrib><creatorcontrib>Olson, Jeffrey J.</creatorcontrib><creatorcontrib>LaRocca, Renato V.</creatorcontrib><creatorcontrib>Browning, James E.</creatorcontrib><creatorcontrib>Brockman, John D.</creatorcontrib><creatorcontrib>Forsyth, Peter A.</creatorcontrib><creatorcontrib>Egan, Kathleen M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer causes & control</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anic, Gabriella M.</au><au>Madden, Melissa H.</au><au>Thompson, Reid C.</au><au>Nabors, L. Burton</au><au>Olson, Jeffrey J.</au><au>LaRocca, Renato V.</au><au>Browning, James E.</au><au>Brockman, John D.</au><au>Forsyth, Peter A.</au><au>Egan, Kathleen M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Toenail iron, genetic determinants of iron status, and the risk of glioma</atitle><jtitle>Cancer causes & control</jtitle><stitle>Cancer Causes Control</stitle><addtitle>Cancer Causes Control</addtitle><date>2013-12-01</date><risdate>2013</risdate><volume>24</volume><issue>12</issue><spage>2051</spage><epage>2058</epage><pages>2051-2058</pages><issn>0957-5243</issn><eissn>1573-7225</eissn><coden>CCCNEN</coden><abstract>Purpose: Iron is essential for oxygen transport and oxidative metabolism; however, elevated iron stores can trigger overproduction of reactive oxygen species and induce DNA damage. Little is known about the association between body iron stores and glioma risk. This study examined the associations of iron levels measured in toenails and genetic variants linked to body iron stores with risk of glioma in a clinic-based case–control study. Methods: Samples were collected a median of 24 days following glioma diagnosis in the cases (10th–90th percentile, range: 10–44 days). Nail iron levels were measured in 300 cases and 300 controls using neutron activation analysis. A total of 24 genetic variants associated with iron status were genotyped in 622 cases and 628 controls. Logistic regression was used to estimate odds ratios (OR) and 95 % confidence intervals (CI) for glioma risk according to toenail iron and the examined genotypes. Results: No association was observed between toenail iron and glioma risk when restricting to cases with nails collected within ∼3 weeks of diagnosis (OR = 0.93; 95 % CI 0.46, 1.87 comparing those with high (≥14 μ/g) vs. low (<6 μ/g) iron levels). In contrast, an inverse association with increasing iron was observed after restricting to cases with a delay of 3 weeks or greater (OR = 0.42; 95 % CI 0.19, 0.95), reflecting potentially insidious effects of advancing disease on iron levels among the cases. No associations were observed for any of the examined genetic variants. Conclusion: The results do not support a role for body iron stores as a determinant of glioma risk.</abstract><cop>Dordrecht</cop><pub>Springer</pub><pmid>23996192</pmid><doi>10.1007/s10552-013-0281-2</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0957-5243 |
ispartof | Cancer causes & control, 2013-12, Vol.24 (12), p.2051-2058 |
issn | 0957-5243 1573-7225 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3823695 |
source | JSTOR Archival Journals and Primary Sources Collection; Springer Link |
subjects | Adolescent Adult Aged Aged, 80 and over Alleles Biomedical and Life Sciences Biomedicine Brain cancer Brain Neoplasms - blood Brain Neoplasms - epidemiology Brain Neoplasms - genetics Brain research Cancer Cancer Research Case-Control Studies Dietary iron DNA damage DNA, Neoplasm - genetics Epidemiology Female Ferritins - blood Follow-Up Studies Genetic testing Genotype Genotypes Glioma Glioma - blood Glioma - epidemiology Glioma - genetics Hematology Humans Iron Iron - metabolism Iron, Dietary Male Medical genetics Metabolism Middle Aged Nails - chemistry Neoplasm Grading Neoplasm Proteins - genetics Neurosurgery Oncology Original Paper P values Polymerase Chain Reaction Prognosis Public Health Risk Factors Survival Rate Toenails Tumors Young Adult |
title | Toenail iron, genetic determinants of iron status, and the risk of glioma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T11%3A14%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Toenail%20iron,%20genetic%20determinants%20of%20iron%20status,%20and%20the%20risk%20of%20glioma&rft.jtitle=Cancer%20causes%20&%20control&rft.au=Anic,%20Gabriella%20M.&rft.date=2013-12-01&rft.volume=24&rft.issue=12&rft.spage=2051&rft.epage=2058&rft.pages=2051-2058&rft.issn=0957-5243&rft.eissn=1573-7225&rft.coden=CCCNEN&rft_id=info:doi/10.1007/s10552-013-0281-2&rft_dat=%3Cjstor_pubme%3E24717889%3C/jstor_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c492t-3b67fb3b9ea84c7ecef3cc76a409054c2072528569a1e39a35df947914a844373%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1448800200&rft_id=info:pmid/23996192&rft_jstor_id=24717889&rfr_iscdi=true |